Latest News

5 Clean Energy Stocks To Buy At Bargain Prices



Pfizer to exit GSK’s consumer health arm after spin-off

LONDON (Reuters) -Pfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with British drugmaker GSK, after the business is spun off as an independent listed company in July, GSK said on Wednesday. Pfizer previously signalled it would seek to sell its shareholding in Haleon, which is home to Sensodyne toothpaste and Advil painkillers, but GSK said in February that the U.S. drugmaker would retain its stake. GSK said on Wednesday that Pfizer would exit its investment in a “disciplined manner”.

Earnings Results: Salesforce stock rallies following raised outlook, with stronger dollar seen as only major headwind

Previous article

Dow Jones Newswires: South Korea posts stronger export growth in May

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News